4//SEC Filing
Cory David A 4
Accession 0001567619-21-014219
CIK 0001305253other
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 4:29 PM ET
Size
5.3 KB
Accession
0001567619-21-014219
Insider Transaction Report
Form 4
Cory David A
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2021-07-29+48,750→ 48,750 totalExercise: $8.15Exp: 2031-07-28→ Common Stock (48,750 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over 36 months measured from July 29, 2021 subject to Reporting Person's continuous service status as of each such date.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001670137
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 4:29 PM ET
- Size
- 5.3 KB